This test is most useful if any of these apply to you.
Most people use sunscreen and personal care products every day without thinking about what gets into their bloodstream. Oxybenzone is one of the most common ultraviolet light filters on store shelves, and it does not stay on your skin. It crosses into your body, circulates, and shows up in urine, blood, breast milk, amniotic fluid, and even umbilical cord blood.
Measuring oxybenzone (benzophenone-3, BP-3) in urine tells you how much of this chemical your body has recently absorbed. It is an exposure marker, not a disease marker, but research links higher levels to signals of hormonal and reproductive disruption. If you want to know whether your daily routine is loading you up with a chemical that has unresolved questions about long-term safety, this is the number to track.
Your body does not make oxybenzone. Every molecule in your urine came from outside, mostly from sunscreens and cosmetics, but also from plastics, textiles, and contaminated water. After absorption through skin (or to a lesser extent through ingestion or inhalation), oxybenzone gets processed by your liver into related compounds and excreted in urine. Urinary levels reflect exposure over roughly the prior 24 to 72 hours, given a measured elimination half-life of about 24 to 31 hours.
Because oxybenzone is fat-soluble, it can also accumulate in fatty tissue and cross the placenta. Studies that have measured paired samples found oxybenzone in maternal serum, placenta, amniotic fluid, and cord blood, with maternal urine serving as a reasonable proxy for fetal exposure. The urine measurement reported in micrograms per gram of creatinine is the most practical way to track your own exposure trend.
The strongest concerns about oxybenzone come from its behavior as a hormone disruptor. In laboratory studies, both oxybenzone and its main metabolite (benzophenone-1, BP-1) bind to estrogen receptors and interfere with other hormonal signaling at concentrations that overlap with what is found in highly exposed humans.
Human studies of healthy women have linked a chemical exposure profile that included oxybenzone to lower estradiol, FSH (follicle-stimulating hormone), and LH (luteinizing hormone), suggesting subtle modulation of the menstrual cycle's hormonal control. Reviews summarizing the human data have flagged signals for altered thyroid hormones, lower testosterone in adolescent males, menstrual irregularities, and a higher reported prevalence of uterine fibroids and endometriosis. None of these associations are settled, but the pattern is consistent enough that researchers consider oxybenzone a plausible endocrine disruptor in real-world doses.
Oxybenzone reaches the fetus. In a study of 600 pregnant women in south China, prenatal exposure to benzophenone-type UV filters was associated with reduced neonatal birth weight and chest circumference, with sex-specific patterns. A separate Middle Eastern cohort of 166 mother-infant pairs reported similar associations between maternal benzophenone derivatives and altered fetal growth.
Among 217 women at a fertility clinic, higher first-trimester urinary oxybenzone was associated with lower pregnancy glucose levels and lower odds of an abnormal glucose tolerance test in some subgroups, an unexpected finding that adds to the picture of metabolic and endocrine effects rather than clearly resolving them.
If oxybenzone disrupts hormones, why does one study link higher exposure in pregnancy to better glucose results? Oxybenzone is not a clean "more is worse" marker. It interacts with multiple hormonal systems, often non-linearly, and the direction of an effect can depend on which tissue, life stage, and co-exposures are involved. The right framework is not "good number versus bad number." It is exposure load: more circulating oxybenzone means more chemical activity at receptors that should not be receiving it. Tracking your level tells you how heavy your exposure burden is, even when individual epidemiological signals point in different directions.
Studies in children have linked higher urinary oxybenzone and related benzophenones to higher TSH (thyroid-stimulating hormone) and lower free T3 (the active thyroid hormone), a pattern consistent with mild thyroid disruption. NHANES data from 1,829 U.S. participants found similar thyroid hormone shifts when oxybenzone was modeled together with phthalate metabolites. Thyroid signals also appeared in a smaller study of children with type 1 diabetes.
Oxybenzone is the most frequently reported allergenic UV filter. It causes both allergic contact dermatitis and photoallergic contact dermatitis (a rash that requires sunlight to develop). Mineral sunscreens with zinc oxide or titanium dioxide do not produce these reactions. If you have unexplained rashes after sun exposure or sunscreen use, your urinary level can document whether oxybenzone is in your system.
There are no clinically validated reference ranges for urinary oxybenzone. The measurement is research-grade. What exists are population distributions from biomonitoring surveys, which show stark geographic and demographic differences.
These figures come from biomonitoring surveys in healthy populations, measured in urine. They are illustrative orientation for thinking about your exposure load, not clinical decision thresholds. Your lab will report a specific concentration in micrograms per gram of creatinine.
| Population Pattern | What Surveys Found | What It Suggests |
|---|---|---|
| North Americans vs Europeans and Asians | Urinary oxybenzone roughly 10 to 20 times higher in North America | Heavy regional use of oxybenzone in personal care products |
| U.S. trends 2003 to 2012 | Urinary levels rose, especially after 2005 to 2006, with consistently higher levels in females and non-Hispanic Whites | Personal care product use is the dominant driver |
| Mothers vs children (Norway) | Detected in nearly 100% of urine samples; mothers higher than children | Adult cosmetic use exceeds child sunscreen exposure on a per-person basis |
Source: HBM4EU meta-analysis (Mustieles et al., 2023); NHANES 2003 to 2012 trend analysis (Han et al., 2015); Norwegian mother-child biomonitoring (Sakhi et al., 2018).
What this means for you: any detectable level confirms recent exposure. Higher levels suggest heavier daily use of products containing oxybenzone or related benzophenones. Because lab assays differ, comparing your own results within the same lab over time gives you the most meaningful trend.
Urinary oxybenzone reflects exposure in roughly the past 24 to 72 hours. A single sample is a snapshot, not a portrait. If you happened to apply sunscreen yesterday, your number will be high regardless of your usual exposure. If you avoided products for several days before the test, it will be artificially low.
Get a baseline that reflects your typical routine. If you change products or behaviors, retest in 4 to 8 weeks. If you are pregnant or planning pregnancy, retest each trimester to confirm exposure stays low. Otherwise, an annual check is reasonable to track whether new product introductions or environmental sources are creeping into your life.
There is no clinical guideline that defines "too high." The practical pathway is to identify and reduce sources, then retest. Audit every product you put on your skin, hair, or lips for benzophenone-3, BP-3, oxybenzone, or 2-hydroxy-4-methoxybenzophenone. Mineral-only sunscreens (zinc oxide and titanium dioxide) do not contribute to your level.
If you are pregnant, planning pregnancy, breastfeeding, or making products available to young children, treat a high reading as a signal to switch sources promptly. If you have unexplained thyroid abnormalities, fertility difficulties, menstrual changes, or a history of uterine fibroids or endometriosis, consider pairing this measurement with thyroid function and reproductive hormone testing to look for patterns. Mention your result to your dermatologist, endocrinologist, or reproductive specialist if any of those workups are underway.
Evidence-backed interventions that affect your OBZ level
Oxybenzone is best interpreted alongside these tests.